Although the genotypes were evenly distributed between NSCLC patients and healthy individuals in current research, no difference were founded between MMP9 polymorphisms and NSCLC with histological type, clinical stage, lymph node metastasis parameters (p > 0.05). Here, MMP9 is linked to metastatic malignant neoplasm in the lymph nodes.